THE ROLE OF DYSLIPIDEMIA, OVERWEIGHT AND DIET IN THE FORMATION OF CARDIOVASCULAR RISK IN HYPERTENSION. REVIEW
Introduction: Cardiovascular disease, including hypertension are the leading causes of mortality in both developed and developing countries. Experience the World of Health showed that the prevention of cardio - vascular diseases significantly reduces mortality. Prevention primarily starts with the impact of risk factors that include obesity, abdominal obesity, smoking, poor nutrition, and іnadequate physical activity.
The aim: A review of literature on the contribution of dyslipidemia, excess body weight and the nature of nutrition in the formation of cardiovascular risk in diseases of the circulatory system.
Materials and methods: Literature search was conducted in the databases Pubmed, Scopus, Ebscohost, Medline, The Socrane Library, Springer Link, Web of Knowledge (Thomson Reuters), Science Direct , Paragraph Medicine, Google academia,. The depth of the search was 30 years: from 1986 to 2016.
The inclusion criteria were: reports on randomized and cohort studies conducted on large populations; Meta-analyzes and systematic reviews. Criteria for exclusion were: articles describing single cases and a series of cases. Out of 150 literary sources, 60 were selected as analytical material for this article.
Results: Review sources revealed that the majority of authors are similar, in that the magnitude of hypertension cardiovascular risk is related to the nature of dyslipidemia and the presence and degree of excess body weight, lifestyle and nutrition of patients.
Conclusions: To effectively reduce cardiovascular risk and prevent complications in patients with arterial hypertension, at all stages of medical care, in addition to controlling lipid metabolism parameters, it is necessary to promote the formation of habits of a healthy lifestyle and rational nutrition.
Aizhan Т. Shakhanova, http://orcid.org/0000-0001-8214-8575
Dana К. Kozhakhmetova, http://orcid.org/0000-0002-8367-1461
Alma U. Nurtazina, http://orcid.org/0000-0002-9737-4003
Semey State Medical University, Department of the general medical practice,
Semey c., Kazakhstan
1. Kazakhstan Respublikasynyn densaulyk saktau salasyn damytudyn 2016-2020 zhyldarga arnalgan «Densaulyk» memlekettіk bagdarlamasy [The development of Health of the Republic of Kazakhstan for 2016-2020 "Health" program. 2016, рр. 1-32. (reference date: 23.02.17)] www.amu.kz
2. Titov V.N., Vostrov I.A., Kaba S.I., Amelyushkina V.A. Lipoproteiny nizkoi i ochen' nizkoi plotnosti: patogeneticheskoe i klinicheskoe znachenie [Lipoproteins of low and very low density: pathogenetic and clinical significance, Klinicheskaya meditsina [Clinical medicine], 2013, T1. №3. pp. 20-27
3. Allan C.M., Walker D., Segrest J.P. Identification and characterization of a new human gene (APOC4) in the apolipoprotein E, C-I, and C-II gene locus. Genomics. 1995, Jul 20; 28(2), 291-300.
4. Anderson T.J. et. al. Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Can. J. Cardiol. 2013, Т. 29. № 2, pp. 151–167.
5. Badheka A.O. et. al. Influence of Obesity on Outcomes in Atrial Fibrillation: Yet Another Obesity Paradox. Am. J. Med. 2010, Т. 123. № 7, С. 646–651.
6. Bibbins-Domingo K. et. al. Projected effect of dietary salt reductions on future cardiovascular disease. N. Engl. J. Med. 2010, Т. 362. № 7. pp. 590–9.
7. Calle E.E. et. al. Body-Mass Index and Mortality in a Prospective Cohort. N. Engl. J. Med. 1999. Т. 341. № 15. pp. 1097–1105.
8. Carlos Lorenzo, Sara Hartnett, Anthony J. Hanley, Marian J. Rewers, Lynne E. Wagenknecht, Andrew J. Karter and Steven M.H. Impaired Fasting Glucose and Impaired Glucose Tolerance Have Distinct Lipoprotein and Apolipoprotein Changes: The Insulin Resistance Atherosclerosis Study. 2013. pp. 1622–1630.
9. Carnethor M.R., de Chavez P.J., Biggs M.L., Lewis C.E., Pankow J.S., Bertoni A.G., Golden S.H. Association of Weight Status with Mortality in Adults with Incident Diabetes. JAMA. 2012. Т. 308. № 6. pp. 581–590.
10. Conlin P.R. et. al. The effect of dietary patterns on blood pressure control in hypertensive patients: Results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am. J. Hypertens. 2000. Т. 13. № 9. pp. 949–955.
11. Conroy R.M. et. al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur. Heart J. 2003. Т. 24. № 11. pp. 987–1003.
12. Cooney M.T., Dudina A.L., Graham I.M. Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk. A Review for Clinicians. J. Am. Coll. Cardiol. 2009. Т. 54. № 14. pp. 1209–1227.
13. Coutinho T. et. al. Central obesity and survival in subjects with coronary artery disease: A systematic review of the literature and collaborative analysis with individual subject data. J. Am. Coll. Cardiol. 2011. Т. 57. № 19. pp. 1877–1886.
14. Diaf M., Khaled B.M. Impact of corpulence parameters and haemoglobin A1c on metabolic control in type 2 diabetic patients: comparison of apolipoprotein B/A-I ratio with fasting and postprandial conventional lipid ratios. Libyan J. Med. 2015. Т. 1. pp. 1–10.
15. Dickinson H.O. et. al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J. Hypertens. 2006. Т. 24. № 2. pp. 215–33.
16. Du T. et. al. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc. Diabetol. 2014. Т. 13. № 1. pp. 146.
17. Elmer P.J. et. al. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med. 2006. Т. 144. № 7. pp. 485–495.
18. Ferns G.D. Haplotypes of the human apoprotein AI-CIII-AIV gene cluster in coronary atherosclerosis. 1986. pp. 245–9.
19. Frisoli T.M. et. al. Beyond salt: Lifestyle modifications and blood pressure. Eur. Heart J. 2011. Т. 32. № 24. pp. 3081–3087.
20. Haines P.S., Siega-Riz A.M., Popkin B.M. The Diet Quality Index Revised: A measurement instrument for populations. J. Am. Diet. Assoc. 1999. Т. 99. № 6. pp. 697–704.
21. Hamer M., Stamatakis E. Overweight and obese cardiac patients have better prognosis despite reporting worse perceived health and more conventional risk factors. Prev. Med. (Baltim). 2013. Т. 57. № 1. pp. 12–16.
22. Hippisley-Cox J. et. al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ. 2008. Т. 336. № 7659. pp. 1475–1482.
23. Huot I. et. al. Correlates of diet quality in the Quebec population. Public Health Nutr. 2004. Т. 7. № 8. pp. 1009–1016.
24. Jenkins D.J.A. et. al. The effect of a dietary portfolio compared to a DASH-type diet on blood pressure. Nutr. Metab. Cardiovasc. Dis. 2015. Т. 25. № 12. pp. 1132–1139.
25. Kant A.K. et. al. A prospective study of diet quality and mortality in women. JAMA. 2000. Т. 283. № 16. pp. 2109–15.
26. Kant A.K. Dietary Patterns and Health Outcomes. 2004. С. 1.
27. Kant A.K., Thompson F.E. Measures of overall diet quality from a food frequency questionnaire: National Health Interview Survey, 1992. Nutr. Res. 1997. Т. 17. № 9. pp. 1443–1456.
28. Karasek D. et. al. Prehypertension in dyslipidemic individuals; relationship to metabolic parameters and intima-media thickness. Biomed. Pap. 2013. Т. 157. № 1. pp. 41–49.
29. Kim 3.I. et. al. A Study on the Anthropometric and Biochemical Characteristics of Pre-hypertensive and Hypertensive Patients in Gyeongnam Area. 2014. pp. 127–138.
30. Klos K.L. et. al. APOA5 polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study. J. Lipid Res. 2005. Т. 46. № 3. pp. 564–71.
31. Lakka H.M. et. al. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur. Heart J. 2002. Т. 23. № 9. pp. 706–713.
32. León-Muñoz L.M. et. al. Dietary habits of the hypertensive population of Spain: accordance with the DASH diet and the Mediterranean diet. J. Hypertens. 2012. Т. 30. № 7. pp. 1373–82.
33. Li W. et. al. The apo ipoprotein multigene fam ly : biosynthesis, structure, structure-function relationships. J. Lipid Res. 1988. Т. 29. pp. 245–271.
34. MacMahon S. et. al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009. Т. 373. № 9669. pp. 1083–1096.
35. Marcovina S.M. et. al.International federation of clinical chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of international reference material. Clin. Chem. 1994. Т. 40. № 4. pp. 586–592.
36. Massari M. et. al. An index to measure the association between dietary patterns and coronary heart disease risk factors: findings from two Italian studies. Prev. Med. (Baltim). 2004. Т. 39. № 4.pp. 841–847.
37. Nelson M.R. et. al. Influence of apolipoprotein E genotype variation on the means, variances, and correlations of plasma lipids and apolipoproteins in children. Ann. Hum. Genet. 1999. Т. 63. № Pt 4. pp. 311–28.
38. Okamura T. et. al. Serum level of LOX-1 ligand containing ApoB is associated with increased carotid intima-media thickness in Japanese community-dwelling men, especially those with hypercholesterolemiaLOX-1 ligand and IMT in Japanese. J. Clin. Lipidol. 2016. Т. 10. № 1. pp. 172–180e1.
39. Osler M. et. al. Dietary patterns and mortality in Danish men and women: a prospective observational study. Br. J. Nutr. 2001. Т. 85. № 2. pp. 219.
40. Patterson R.E., Haines P.S., Popkin B.M. Diet quality index: Capturing a multidimensional behavior. J. Am. Diet. Assoc. 1994. Т. 94. № 1. pp. 57–64.
41. Pereira M. et. al. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J. Hypertens. 2009. Т. 27. № 5. pp. 963–975.
42. Pimenta E. et. al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertens. (Dallas, Tex. 1979). 2009. Т. 54. № 3. pp. 475–81.
43. Qi L. et. al. Prevalence and risk factors associated with dyslipidemia in Chongqing, China. Int. J. Environ. Res. Public Health. 2015. Т. 12. № 10. pp. 13455–13465.
44. Ramón Durazo-Arvizu P. et. al. Relative weight and mortality in U.S. blacks and whites: Findings from representative national population samples. 1997. pp. 383–395.
45. Reiner Ž. et. al. ESC/EAS Guidelines for the management of dyslipidaemias. Eur. Heart J. 2011. Т. 32. № 14. рр. 1769–1818.
46. Robinson J.G. et. al. Meta-Analysis of the Relationship Between Non-High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk. J. Am. Coll. Cardiol. 2009. Т. 53. № 4. pp. 316–322.
47. Ryoo J.H. et. al. Clinical significance of serum apolipoproteins as a predictor of coronary heart disease risk in Korean men. Clin. Endocrinol. (Oxf). 2016. Т. 84. № 1. pp. 63–71.
48. Sacks F. et. al. DASH - Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary approaches to stop Hypertension (DASH) diet. N Engl J Med. 2001. Т. 344. № 1. pp.3–10.
49. Shahar D. и др. Development of a food frequency questionnaire (FFQ) for an elderly population based on a population survey. J Nutr. 2003. Т. 133. № August. pp. 3625–3629.
50. Sing C.F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am. J. Hum. Genet. 1985. Т. 37. № 2. pp. 268–285.
51. Stengård J.H. et. al. Contribution of regulatory and structural variations in APOE to predicting dyslipidemia. J. Lipid Res. 2006. Т. 47. № 2. pp. 318–328.
52. Talmud P.J. et. al. Relative contribution of variation within the APOC3 / A4 / A5 gene cluster in determining plasma triglycerides. 2002. Т. 11. № 24. pp. 78-84.
53. Toft U. et. al. The Dietary Quality Score: validation and association with cardiovascular risk factors: the Inter99 study. Eur. J. Clin. Nutr. 2007. Т. 61. pp.270–278.
54. Trichopoulou A. et. al. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003. Т. 348. № 26. pp. 2599–2608.
55. Tucker K.L. et. al. The combination of high fruit and vegetable and low saturated fat intakes is more protective against mortality in aging men than is either alone: the Baltimore Longitudinal Study of Aging. J. Nutr. 2005. Т. 135. № 10, 2004. pp. 556–561.
56. Tuomilehto J. et. al. Advanced Framework for a New Diagnosis of Obesity As a Chronic Disease. Eur. Heart J. 2014. Т. 23. № 9. pp. 706–713.
57. Waili D. et. al. Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int. J. Cardiol. 2012. pp. 162(1):20-6.
58. Wong W. -m. R. Apolipoprotein AIV Gene Variant S347 Is Associated With Increased Risk of Coronary Heart Disease and Lower Plasma Apolipoprotein AIV Levels. Circ. Res. 2003. Т. 92. № 9. pp. 969–975.
59. Zhang X. et. al. Detection of circulating IgG antibodies to apolipoprotein B100 in acute myocardial infarction FEBS Open Bio. 2015. Т. 5. pp. 712–716.
60. Zheng W. et. al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011. Т. 364. № 8. pp. 719–729.